Royal Bank of Canada Raises IDEAYA Biosciences (NASDAQ:IDYA) Price Target to $61.00
IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its price objective raised by Royal Bank of Canada from $53.00 to $61.00 in a research note issued to investors on Thursday, Benzinga reports. They currently have an outperform rating on the stock. Other equities analysts have also issued reports about the stock. Mizuho assumed coverage on shares […]
More Stories
LGI Homes, Inc. (NASDAQ:LGIH) Given Consensus Rating of “Hold” by Analysts
Shares of LGI Homes, Inc. (NASDAQ:LGIH – Get Free Report) have received an average recommendation of “Hold” from the five...
Xponential Fitness, Inc. (NYSE:XPOF) Receives $18.25 Average PT from Brokerages
Shares of Xponential Fitness, Inc. (NYSE:XPOF – Get Free Report) have been given an average recommendation of “Moderate Buy” by...
Getty Realty (NYSE:GTY) Price Target Raised to $33.00 at JPMorgan Chase & Co.
Getty Realty (NYSE:GTY – Get Free Report) had its price target increased by stock analysts at JPMorgan Chase & Co....
General Mills (NYSE:GIS) Rating Reiterated by Royal Bank of Canada
General Mills (NYSE:GIS – Get Free Report)‘s stock had its “sector perform” rating reaffirmed by stock analysts at Royal Bank...
Sun Communities (NYSE:SUI) Given New $154.00 Price Target at Wells Fargo & Company
Sun Communities (NYSE:SUI – Get Free Report) had its price target increased by equities research analysts at Wells Fargo &...
OUTFRONT Media (NYSE:OUT) Coverage Initiated at Wells Fargo & Company
Equities research analysts at Wells Fargo & Company assumed coverage on shares of OUTFRONT Media (NYSE:OUT – Get Free Report)...